|
|
|
|
The
Peter Mac Apheresis Service contributes to the provision of patient
care by providing blood cell therapies to both inpatients and day
patients and as a collection facility for donor products that are
required to support patients (at Peter Mac and other hospitals) as
part of their treatment program.
All procedures are undertaken in an environment of best practice activities,
quality systems complains and excellence in patient and donor management.
As
part of the Peter Mac Centre for Blood Cell Therapies, the Apheresis
Service is also the first therapeutic service to implement cGMP quality
systems and be audited by TGA. This is a considerable investment in
ensuring patient, donor and product continual improvement and best
practice.
Unit Manager
Eve Eaton RN B. Health Sciences/Nursing
Ph: 03 9656 1219 Fax: 03 9656 1908 |
|
|
|
|
|
|
Peter
MacCallum Cancer Centre, St Andrews Place, East Melbourne VIC
3002
Ph: (03) 9656 1111, Fax (03) 9656 1400 (Melway Refrence Map 2G:A2) |
| |
 |
MAP |
| |
|
DIRECTION |
|
|
|
|
|
|
Service
Hours |
|
|
|
|
Usual
Hours: Monday to Friday (excluding public holidays) 8.00am -
4.30pm |
| |
|
After
Hours: On Call Service (after usual hours, public holidays and
weekends) |
| |
|
Procedures
are scheduled by appointment only after confirmation from apheresis
unit staff. |
|
|
|
|
Patient
Information: |
|
|
|
Clinician
Information
Patient referrals and donor product support requests are made directly
to the nursing staff of the Apheresis Service. Referral form MR/56
is completed for all requests and filed in the record, along with
the Procedure Record MR/57A. Clinical activities are overseen or approved
as necessary by Dr Miles Prince, Director CBCT. Information regarding
the requirements and organisation of clinical procedures is available
from the nursing staff on ext 1219 or on call mobile (via switch).
Specialised
Diagnostics
Procedures undertaken utilising Apheresis technologies include: |
|
Peripheral
Blood Stem Cell Collections |
|
Granulocyte
Collections |
|
Plasma
Exchange |
|
Leukocyte
Reduction |
|
Red
Cell Reduction |
|
Blood
Component Collections for Trials / Research |
|
| Other
procedures include: |
|
Cellular
Product (RCC, Pit) Transfusions |
|
Immunoglobulin
Infusions |
|
Central
Venous Catheter management |
|
Growth
Factor / cytokine injections |
|
Blood
sample collection |
|
| Clinical
Trials - as per CBCT |
|
| Key
References: |
|
The
word Apheresis originates from Greek and means 'to take away
from'. It refers to a number of procedures that involve the
removal and separation of blood into its components, collection,
and/or treatment and return of the components to the individual.
The concept of apheresis has been applied to blood donation
as well as patient treatment and has become an important part
of transfusion practice and patient support - predominantly
oncology and neurology. |
| |
|
|
|
